Clinical Trial Update: L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL [Phase 1]

View source ↗

Summary

Phase 1 trial of Eryaspase (L-asparaginase encapsulated in red blood cells) for adult acute lymphoblastic leukemia or lymphoblastic lymphoma has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Eryaspase (pegylated asparaginase)

Snippet

Sponsor: ERYtech Pharma | Conditions: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 1 | Status: TERMINATED